Newcelx Ltd NCEL

$2.90 -0.14 (-4.63%)

Valuation

Market cap
17,588,000
Revenue TTM
$0
Net income TTM
$-8,300,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.06

Trading

Volume
1,100
Avg volume
8,166
Day's range
$2.90 – $2.96
Shares out
5,776,000
Stochastic %K
29%
Beta
0.99
Analysts
Strong Buy
Price target
—

Price

Company profile

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and...

Show more

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.

Industry
Biotechnology
Sector
Healthcare
Phone
41 44 512 21 50
Website
https://newcelx.com
Address
Hohstrasse 1, Kloten, Switzerland

Latest news

Stocktwits

PrintingGains Sep 11, 1:00 AM
$NCEL where is everyone???
0 replies
DonCorleone77 Aug 21, 12:47 AM
$OSIS $AVAH $NCEL AFTER-HOURS MOVERS: Currently Higher After Earnings: - Ross Stores (ROST) up 8.7% Currently Also Higher: - Spotify Technology (SPOT) up 0.9% after boosting share buyback Currently Lower After Earnings: - Flux Power (FLUX) down 23.8% - Flowers Foods (FLO) down 4.5% - OSI Systems (OSIS) down 13.4% Currently Also Lower: - Aveanna Healthcare (AVAH) down 8.6% after equity offering - NewcelX Ltd. (NCEL) down 5.0% after selling stock for holders.
0 replies
ShutupGhaleon Aug 10, 6:43 PM
$NCEL This has to be my favorite stock. It drops every single day, there's very little volume and management is more secretive than the CIA. I'm thinking it could hit $4 by 2046.
0 replies
focafoca99 Jul 31, 1:47 PM
$NCEL notified pricing of a $1.4 million equity financing at a 20% premium.
0 replies
focafoca99 Jul 15, 5:40 PM
$NCEL recently secured a Brazilian patent for its NCEL-101 Type 1 diabetes therapy, expanding its IP portfolio.
0 replies
kshonstocks Jul 9, 3:32 PM
$NCEL on scans has the higher high and is hod here
0 replies
focafoca99 Jul 8, 1:51 PM
$NCEL recruited Dr. Camillo Ricordi to its Scientific Advisory Board.
0 replies
macec Jul 6, 5:01 PM
$NCEL what’s going on here?
0 replies